Every earnings call for MOREPENLAB — management tone, guidance, KPIs and promise tracking, quarter by quarter.
MOREPENLAB · 5 transcripts · Healthcare · latest Q4 FY25Revenue (Annual) ₹1,830 cr (+7% YoY); EBITDA Margin (Annual) 10.5% (+0% YoY). FY25 Revenue reached INR1,830 crores, marking a 7.4% increase YoY.
Read full transcript & analysisRevenue (9M FY25) ₹1,359 cr (+6% YoY); EBITDA Margin (9M FY25) 10.71% (+21% YoY); PAT (9M FY25) ₹98 cr (+44% YoY). Nine-month FY25 revenue grew 6.5% to ₹1,359 crores.
Read full transcript & analysisRevenue ₹445 cr (+4% YoY); EBITDA ₹49 cr (+33% YoY); PAT ₹35 cr (+64% YoY). Q2 FY25 Revenue stood at INR 444.71 crores, with H1 FY25 revenue at INR 901 crores.
Read full transcript & analysisRevenue ₹459 cr (+14% YoY); EBITDA ₹55 cr (+93% YoY); EBITDA Margin 12.0%. Revenue increased by 14% YoY to ₹458.64 crores in Q1 FY25.
Read full transcript & analysisFY24 Revenue ₹1,704 cr (+20% YoY); FY24 EBITDA ₹173 cr (+101% YoY); FY24 PAT ₹97 cr (+150% YoY). FY24 Revenue of ₹1,704 crores, up 20% YoY.
Read full transcript & analysis